IRGACARE®† MP-Coated Plus Sutures
Have a strong record of
effectiveness and safety

- The generic form of IRGACARE® MP, triclosan, has been used safely and effectively in a wide variety of over-the-counter healthcare and consumer products for over 30 years1
- The IRGACARE® MP antibacterial coating actively inhibits the growth of certain pathogens on the suture most commonly associated with SSIs4-6
- Plus Sutures with IRGACARE® MP creates an effective zone of inhibition, which has been proven in in vitro studies4-6
- As an antiseptic, IRGACARE® MP has no proven clinical connection with antibiotic resistance2,3
- SSIs are a serious risk for patients and have real consequences for physicians and healthcare organizations7
- Over 120 million strands of Ethicon IRGACARE® MP-coated Plus SUTURES have been implanted in patients worldwide8





